Clinical Trial

Safety, PK and PD of FLQ-101 in Premature Neonates

Name: Safety, PK and PD of FLQ-101 in Premature Neonates — clinical trial record (NCT07093255)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: tROPhy-1

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate safety and efficacy outcomes following exposure to FLQ-101.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-23.

Status change: Not Yet Recruiting → Recruiting 2026-04-16

Trial Details

NCT Number	NCT07093255
Lead Sponsor	FELIQS INC.
Conditions	Retinopathy of Prematurity (ROP)
Enrollment	18 participants
Start Date	2026-04-03
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-21